Cipron Tablet (Ciprofloxacin Hydrochloride Monohydrate)
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.
MFDS item code 201902739 · Approved 2019.04.29
This product's status changed to Expired on 2024.04.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of genitourinary, respiratory, ear, nose and throat, eye, gastrointestinal, peritoneal, skin, and osteoarticular infections
This medication is used to treat various infections caused by bacteria. It is effective for respiratory infections excluding acute bronchitis and pneumonia occurring in the community. It is also used for infections of the ear, nose, throat, bacterial prostatitis, urinary tract infections, gonococcal cervicitis, and urethritis. It is applicable for gastrointestinal infections, infections of the bile duct, skin and soft tissue infections, bone and joint infections, gynecological infections, peritonitis, Bartholin's cysts, tendinitis, and acute bacterial exacerbation of chronic obstructive pulmonary disease. However, it is recommended to use it only when there are no other treatment options for certain mild infections. This drug carries a risk of serious adverse reactions and is used to improve various infections.
○ Usual adult dosage: Administer ciprofloxacin 250 ~ 500 mg orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms have disappeared. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/min: Administer 250 ~ 500 mg twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients undergoing hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Male: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Female: 0.85 × the value calculated for males 6) For severe infections, the single dose may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Adjust the dose appropriately according to symptoms.
This drug may cause serious tendon-related side effects, such as tendinitis or tendon rupture. If such symptoms occur, discontinue use immediately and consult a healthcare professional. Peripheral neuropathy and central nervous system abnormal symptoms have also been reported; caution is needed. Patients with myasthenia gravis should avoid this drug as it may worsen symptoms. This medication is prescribed only for specific bacterial infections and is recommended to be administered only when no other treatment options are available. Elderly patients, patients with reduced kidney function, transplant recipients, and those on corticosteroid therapy are at an increased risk of tendon rupture and should be cautious. Co-administration with corticosteroids should be avoided, and if tendon pain or inflammation occurs, rest and limitation of activity are required. Patients with epilepsy or a history of seizures may have an increased risk of seizures and should use this drug with caution. This medication should not be used during pregnancy or lactation, or in growing adolescents under 18 years of age. Patients with drug hypersensitivity or those who have previously experienced tendinitis or tendon rupture with similar drugs should also avoid use. Additionally, serious side effects may occur when combined with certain medications, so it is essential to inform healthcare professionals of any current medications. During the course of treatment with this drug, it is important to avoid strong sunlight or ultraviolet exposure, and if any photosensitivity reactions occur, treatment should be discontinued immediately. Diabetic patients with difficulty controlling blood sugar should carefully monitor for blood sugar changes and seek immediate treatment for symptoms of hypoglycemia. Caution should be taken while driving or operating machinery, as dizziness or drowsiness may occur. If severe diarrhea or abdominal pain develops during treatment, it may indicate the possibility of pseudomembranous colitis; consult a healthcare professional immediately. In cases of overdose, kidney function may be affected, so adherence to the prescribed dose is crucial, and renal function tests should be conducted as needed. This drug is not recommended for children as its safety has not been established. Elderly patients may require dosage adjustments due to potential increases in drug concentration from reduced kidney function. Medications should be stored in a tightly sealed container to avoid exposure to air and at room temperature between 1 to 30 degrees Celsius to maintain efficacy.
Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, venous thrombosis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, hematocrit decrease, agranulocytosis, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reactions, anaphylactoid shock, serum sickness-like reactions, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin level, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, sensory loss, loss of taste, tremors, seizures, vertigo, mental confusion, convulsions, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, ataxia, polyneuropathy, visual disturbances, color vision disorders, diplopia, tinnitus, hearing loss, transient hearing loss, auditory impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular arrhythmias, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, colitis with hematochezia, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, hepatic necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and cramps, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aneurysm, aortic dissection, heart valve regurgitation, heart valve insufficiency, shock, hypotension, chest tightness, muscle weakness, rhabdomyolysis, cough, chest X-ray abnormalities, eosinophilia, interstitial pneumonia, visual impairment
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291.5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Ciprofloxacin Hydrochloride
Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 582mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.